Overview

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This is a 2-year, open-label, randomized study to evaluate the efficacy of Rosuvastatin dosing adjustment by LDL-C level compared to that of 5mg maintenance dose in chinese patients with Carotid Atherosclerosis.

Phase:

Phase 4

Details

Lead Sponsor:

Wei Liu

Collaborators:

AstraZeneca
Beijing Clinstech-med consulting Co., Ltd
University of Washington

Treatments:

Rosuvastatin Calcium